182 related articles for article (PubMed ID: 15012571)
1. 7: Treatment of osteoporosis: why, whom, when and how to treat. The single most important consideration is the individual's absolute risk of fracture.
Seeman E; Eisman JA
Med J Aust; 2004 Mar; 180(6):298-303. PubMed ID: 15012571
[TBL] [Abstract][Full Text] [Related]
2. Medical treatment of vertebral osteoporosis.
Lippuner K
Eur Spine J; 2003 Oct; 12 Suppl 2(Suppl 2):S132-41. PubMed ID: 13680313
[TBL] [Abstract][Full Text] [Related]
3. Treatment of osteopenia.
Eriksen EF
Rev Endocr Metab Disord; 2012 Sep; 13(3):209-23. PubMed ID: 21710179
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous Insufficiency Fractures.
Brennan M; O'Shea PM; O'Keeffe ST; Mulkerrin EC
J Nutr Health Aging; 2019; 23(8):758-760. PubMed ID: 31560035
[TBL] [Abstract][Full Text] [Related]
5. Comparison of bone mineral density in forearm and hip regions and evaluation of area of these 2 sites.
Rajaei A; Abbasi Z; Emam MM; Ahmadzadeh A; Farsad F; Sadraee H
J Family Med Prim Care; 2022 Dec; 11(12):7725-7734. PubMed ID: 36994045
[TBL] [Abstract][Full Text] [Related]
6. Assessing salivary matrix metalloproteinase-8 in prostate cancer patients undergoing androgen deprivation therapy.
Memon MA; Aleem B; Memon HA; Lee KY
Clin Exp Dent Res; 2022 Oct; 8(5):1277-1283. PubMed ID: 35769040
[TBL] [Abstract][Full Text] [Related]
7. Effect of osteoporosis-related reduction in the mechanical properties of bone on the acetabular fracture during a sideways fall: A parametric finite element approach.
Khakpour S; Esrafilian A; Tanska P; Mononen ME; Korhonen RK; Jämsä T
PLoS One; 2022; 17(2):e0263458. PubMed ID: 35130332
[TBL] [Abstract][Full Text] [Related]
8. Simplified Tai Chi Resistance Training versus Traditional Tai Chi in Slowing Bone Loss in Postmenopausal Women.
Wang H; Yu B; Chen W; Lu Y; Yu D
Evid Based Complement Alternat Med; 2015; 2015():379451. PubMed ID: 26136808
[TBL] [Abstract][Full Text] [Related]
9. In vivo experimental study on bone regeneration in critical bone defects using PIB nanogels/boron-containing mesoporous bioactive glass composite scaffold.
Chen X; Zhao Y; Geng S; Miron RJ; Zhang Q; Wu C; Zhang Y
Int J Nanomedicine; 2015; 10():839-46. PubMed ID: 25653525
[TBL] [Abstract][Full Text] [Related]
10. Association of the MTHFR C677T polymorphism and bone mineral density in postmenopausal women: a meta-analysis.
Li D; Wu J
J Biomed Res; 2010 Nov; 24(6):417-23. PubMed ID: 23554658
[TBL] [Abstract][Full Text] [Related]
11. Biocompatibility of chitosan-coated iron oxide nanoparticles with osteoblast cells.
Shi SF; Jia JF; Guo XK; Zhao YP; Chen DS; Guo YY; Cheng T; Zhang XL
Int J Nanomedicine; 2012; 7():5593-602. PubMed ID: 23118539
[TBL] [Abstract][Full Text] [Related]
12. Time to onset of efficacy in fracture reduction with current anti-osteoporosis treatments.
Inderjeeth CA; Chan K; Kwan K; Lai M
J Bone Miner Metab; 2012 Sep; 30(5):493-503. PubMed ID: 22643863
[TBL] [Abstract][Full Text] [Related]
13. Methodological reflections on using pilot data from fracture patients to develop a qualitative study.
Otmar R; Kotowicz MA; Nicholson GC; Pasco JA
BMC Res Notes; 2011 Nov; 4():508. PubMed ID: 22112387
[TBL] [Abstract][Full Text] [Related]
14. Nutritional approach for inhibiting bone resorption in institutionalized elderly women with vitamin D insufficiency and high prevalence of fracture.
Bonjour JP; Benoit V; Pourchaire O; Rousseau B; Souberbielle JC
J Nutr Health Aging; 2011 May; 15(5):404-9. PubMed ID: 21528169
[TBL] [Abstract][Full Text] [Related]
15. Patterns of treatment in Australian men following fracture.
Otmar R; Henry MJ; Kotowicz MA; Nicholson GC; Korn S; Pasco JA
Osteoporos Int; 2011 Jan; 22(1):249-54. PubMed ID: 20229198
[TBL] [Abstract][Full Text] [Related]
16. Absolute risk reduction in osteoporosis: assessing treatment efficacy by number needed to treat.
Ringe JD; Doherty JG
Rheumatol Int; 2010 May; 30(7):863-9. PubMed ID: 20035331
[TBL] [Abstract][Full Text] [Related]
17. Bone health and back pain: what do we know and where should we go?
Briggs AM; Straker LM; Wark JD
Osteoporos Int; 2009 Feb; 20(2):209-19. PubMed ID: 18716821
[TBL] [Abstract][Full Text] [Related]
18. Drug Insight: choosing a drug treatment strategy for women with osteoporosis-an evidence--based clinical perspective.
Geusens PP; Roux CH; Reid DM; Lems WF; Adami S; Adachi JD; Sambrook PN; Saag KG; Lane NE; Hochberg MC
Nat Clin Pract Rheumatol; 2008 May; 4(5):240-8. PubMed ID: 18398411
[TBL] [Abstract][Full Text] [Related]
19. [Metabolic bone diseases].
Jakob F
Internist (Berl); 2007 Oct; 48(10):1101-17. PubMed ID: 17882394
[TBL] [Abstract][Full Text] [Related]
20. Individualization of osteoporosis risk.
Nguyen TV
Osteoporos Int; 2007 Sep; 18(9):1153-6. PubMed ID: 17611705
[No Abstract] [Full Text] [Related]
[Next] [New Search]
